Dana Pharmaceutical Company (DEDANA) financial ratios
Every ratio computed for this symbol, period by period, beside its industry and its own board
- Ticker
- DEDANA
- Industry
- Pharmaceuticals
- Market
- Iran Fara Bourse
Latest periods
| Item | Report to 1404/09/30 | Report to 1402/12/29 | Report to 1401/12/29 | Report to 1400/12/29 |
|---|---|---|---|---|
| P/E TTM | 4.86 | 5.96 | 9.46 | 23.95 |
| P/S TTM | 1.37 | 1.70 | 3.73 | 12.67 |
| P/B | 2.26 | 3.68 | 6.09 | 15.23 |
| Gross margin TTM | 49.4% | 46.8% | 55.4% | 67.3% |
| Net margin TTM | 28.3% | 28.4% | 39.4% | 52.6% |
| ROA TTM | 19.6% | 22.7% | 28.2% | 35.5% |
| ROE TTM | 46.6% | 61.8% | 64.4% | 63.6% |
| Collection period TTM | 280 days | 229 days | 225 days | 233 days |
| Inventory period TTM | 129 days | 130 days | 189 days | 328 days |
| PEG TTM | 0.09 | 0.17 | 0.24 | 0.59 |
| PEGY TTM | 0.07 | 0.13 | 0.19 | 0.48 |